Novo Integrated Sciences, Inc. Goodwill, Impairment Loss
Novo Integrated Sciences, Inc. reported Goodwill, Impairment Loss of $1.00 million for the 12-month period ending 2024-08-31, per its 10-K filed 2024-12-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GoodwillImpairmentLoss · last filed 2024-12-18
- Novo Integrated Sciences, Inc. goodwill, impairment loss for fiscal 2024 was $1.00M.
- Novo Integrated Sciences, Inc. goodwill, impairment loss for fiscal 2022 was $1.36M, a 1265.91% increase from fiscal 2021.
- Novo Integrated Sciences, Inc. goodwill, impairment loss for fiscal 2021 was $99.35K.
- Novo Integrated Sciences, Inc. goodwill, impairment loss for fiscal 2019 was $188.65K.
| Period end | Goodwill, Impairment Loss 9 month | Goodwill, Impairment Loss 12 month | Goodwill, Impairment Loss 12 month as first filed |
|---|---|---|---|
| 2024-08-31 | $1.00M 10-K · filed 2024-12-18 | ||
| 2023-05-31 | $1.36M 10-Q · filed 2023-07-17 | ||
| 2022-08-31 | $1.36M 10-K · filed 2023-12-14 | ||
| 2021-08-31 | $99.35K 10-K · filed 2023-04-03 | $99.59K 10-K · filed 2021-12-14 | |
| 2019-08-31 | $188.65K 10-K · filed 2020-12-09 | -$188.65K 10-K · filed 2019-11-20 |